Influence of atherosclerosis‐related risk factors on serum high‐sensitivity C‐reactive protein levels in patients with type 2 diabetes: Comparison of their influence in obese and non‐obese patients

Abstract

Aims/IntroductionIncreased levels of high‐sensitivity C‐reactive protein (hs‐CRP) likely leads to the development of atherosclerosis. Therefore, it is very important to know which factors largely influence hs‐CRP levels. In the present study, we examined the influence of various atherosclerosis‐related factors on hs‐CRP levels in patients with type 2 diabetes.Materials and MethodsA total of 275 patients (176 men, 99 women) were enrolled in this study. We tested the relationship between the number of risk factors reaching a desired value and hs‐CRP levels. The Mann–Whitney U‐test was used to compare two groups. The Kruskal–Wallis test was used to carry out overall group comparisons, and the Steel–Dwass test was used to carry out between‐group comparisons. Spearman's rank correlation was carried out to study the correlation between hs‐CRP levels and clinical parameters. Multivariate regression method was used to analyze the factors independently contributing to hs‐CRP levels.ResultsHs‐CRP levels were lower in patients with a larger number of risk factors reaching a desired value. In particular, triglyceride and body mass index (BMI) were independent risk factors determining hs‐CRP levels in a multivariate regression analysis. Furthermore, we compared the influence of various factors on hs‐CRP levels in both obese (BMI ≥25 kg/m2) and non‐obese patients with type 2 diabetes (BMI <25 kg/m2). In obese groups, BMI and urinary albumin were independent risk factors determining hs‐CRP levels, whereas triglyceride and statin were independent risk factors in non‐obese patients.ConclusionsThere is some difference in the factors responsible for hs‐CRP levels in obese and non‐obese patients with type 2 diabetes.

Single and combined effects of inflammatory markers on 10 year diabetes incidence: The mediating role of adiposity—Results from the ATTICA cohort study

“…Various biological mechanisms are postulated to be involved in inflammation‐diabetes relationship. In this study, the main mediator was found to be BMI, which is in line with the recent study of Shimoda et al, who demonstrated that BMI is an important predictor of CRP only among obese patients with diabetes . Obesity‐induced insulin resistance begins in adipose tissue.…”

Associations among Serum Beta 2 Microglobulin, Malnutrition, Inflammation, and Advanced Cardiovascular Event in Patients with Chronic Kidney Disease

“…One of the explanations was eGFR levels did not appear to influence the serum CRP levels, especially in those with early stage CKD (28). Serum CRP was independently associated with albumin, CVEs, and B2M (28)(29)(30). As previous study, the discriminative power of B2M for death was superior to CRP and renal function (30).…”

AMPKα, hs-CRP and FcγR in diabetic nephropathy and drug intervention

“…Hs-CRP is an acute-phase index of micro-inflammatory response that can activate the complement system in the body and enhance the leukocyte phagocytosis by binding to the chromatin and can play a regulatory role by stimulating cell activation ( 16 ). Hs-CRP can cause inflammatory response of the body, which is an important pathological process of DN ( 17 ).…”